Alliance for Multispecialty Research, LLC.

Las Vegas, Nevada 89119

0 studies enrolling now · 16 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Chikungunya Virus, Chikungunya Virus Infection, Chronic Kidney Disease (CKD), Chronic Obstructive Pulmonary Disease, Contraception, Episodic Migraine, Epstein-Barr Virus Infection, Erectile Dysfunction, Gout, Gout Flare, Group B Streptococcus Infections

Studies at this site

• Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination — Running, not enrolling
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• A Study of Cytisinicline for Smoking Cessation in Adult Smokers — Completed
• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens — Completed
• Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers — Completed
• Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive — Stopped early
• A New Sildenafil Oral Film in Patients With Erectile Dysfunction — Completed
• Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• Study of mRNA-1010 Seasonal Influenza Vaccine in Adults — Completed
• A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women — Completed
• A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD — Completed